News
In FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure), the nonsteroidal mineralocorticoid receptor antagonist finerenone reduced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback